Caprock Group’s cbdMD YCBD Stock Holding History

Caprock Group’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-278	Closed	-$295K	–	544
2020 Q4	$295K	Buy	+278	New	+$253K	0.03%	330

Other funds holding YCBD

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caprock Group's YCBD Position: Q1 2021 in Review

Caprock Group sold out of cbdMD (YCBD) in Q1 2021, closing a stake of 278 shares — an estimated $295K sold.

Caprock Group first reported a position in YCBD in Q4 2020 and held it in 1 quarter. The position peaked at $295K in Q4 2020. 52 funds tracked by Wall St. Rank hold YCBD as of Q1 2021.

Caprock Group reported no remaining cbdMD position as of Q1 2021 after selling out during the quarter.
Caprock Group sold 278 cbdMD shares in Q1 2021, an estimated $295K.
Caprock Group first reported a position in cbdMD in Q4 2020 and held it in 1 quarter.
Caprock Group's cbdMD position peaked at $295K in Q4 2020.
52 funds tracked by Wall St. Rank held cbdMD as of Q1 2021.

Based on Caprock Group's 13F filing for Q1 2021, filed 29 Apr 2021.